Navigation Links
Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
Date:12/2/2011

SEATTLE, Dec. 2, 2011 /PRNewswire/ -- Immune Design Corp. announced today that Wayne R. Gombotz, Ph.D. has joined the company as its new Chief Development Officer.  Dr. Gombotz brings a significant amount of product development experience to this key leadership position at Immune Design.  He will oversee product development and manufacturing for Immune Design's therapeutic vaccine product candidates.

(Logo: http://photos.prnewswire.com/prnh/20111018/SF88252LOGO)

Wayne R. Gombotz, Ph.D., most recently served as Vice President of Pharmaceutical Operations at Omeros Corporation from 2005 to 2011. He was responsible for product development and manufacturing for Omeros' pharmaceutical and biopharmaceutical technology platforms.  Prior to this, from 2002 to 2005, Dr. Gombotz was Vice President of Process Science and Pharmaceutical Development at Corixa Corporation.  During the three years he spent at Corixa, he built and led a team that championed immunotherapeutic products.  Corixa was acquired by GlaxoSmithKline plc in 2005.  Prior to joining Corixa, Dr. Gombotz served as a Senior Director of Analytical Chemistry and Formulation at Amgen (formerly Immunex) from 1995 to 2002 where he played a major role in the development and launch of ENBREL®.  He has 25 years of experience providing technical and administrative direction of clinical and commercial manufacturing operations, process development, and process validation functions.  Dr. Gombotz received Ph.D. and M.S. in bioengineering from the University of Washington, Seattle, WA, and received his B.A. in biology from Colby College, Waterville, ME.

"Wayne brings an exceptional and seasoned skill set to Immune Design with very unique capabilities," stated Carlos V. Paya, M.D., Ph.D., President and Chief Executive Officer. "As we looked to expand our leadership team, we sought someone who we believed would bring a unique viewpoint to our research team and be capable of applying that vision to the multidimensional challenge of vaccine discovery and development.  Wayne is exactly that kind of leader."

Dr. Gombotz commented, "I am excited about the opportunity to join Immune Design.  The company has several key technology platforms that provide it with the potential to become a major player in the development of novel vaccines."

About Immune Design Corp.

Immune Design is a privately held, clinical-stage biotechnology company based in Seattle, Washington, and formed in 2008 to bring together some of the world's leaders in the field of molecular immunology to develop vaccines for the treatment and prevention of infectious and malignant disease.  The company employs advanced and leading edge methods to precisely control the activation and context of antigen presentation by dendritic cells in order to shape the desired adaptive immune response.  This goal is accomplished through the application of two proprietary technology platforms that activate the immune system by distinct mechanisms.

Additional information can be found on the company's website at www.immunedesign.com.

Contact Media:

Cassie Ostrander 206-826-7901 or media@immunedesign.com

 

 


'/>"/>
SOURCE Immune Design Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
2. Peptimmune Presentation at Upcoming World Congress on Treatment and Research in Multiple Sclerosis
3. EUPROBIO 2008 Presentation to Highlight Latest Immune Research
4. MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease
5. MedImmune Expands R&D Capacity with New Research Facility in Cambridge, U.K.
6. MedImmune Licenses Reverse Genetics Technology to Hungarys Omninvest for Use in Influenza Vaccine Development and Production
7. MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology
8. Peptimmune Presentations at Upcoming Events
9. Protein-printing technique gives snapshots of immune system defense
10. Visualizing asthma-causing immune cells at work
11. AutoImmune Inc. Reports 2008 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016  Global demand for enzymes ... through 2020 to $7.2 billion.  This market includes ... cleaning products, biofuel production, animal feed, and other ... and biocatalysts). Food and beverages will remain the ... increasing consumption of products containing enzymes in developing ...
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the leading ... the Clinical Reach Virtual Patient Encounter CONSULT module which enables both audio ... and clinical trial team. , Using the CONSULT module, patients and physicians can schedule ...
(Date:6/27/2016)...   Ginkgo Bioworks , a leading organism ... today awarded as one of the World Economic ... most innovative companies. Ginkgo Bioworks is engineering biology ... world in the nutrition, health and consumer goods ... customers including Fortune 500 companies to design microbes ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal ... Their findings are the subject of a new article on the Surviving Mesothelioma website. ... the blood, lung fluid or tissue of mesothelioma patients that can help point doctors ...
Breaking Biology Technology:
(Date:6/22/2016)... -- On Monday, the Department of Homeland Security (DHS) ... for the Biometric Exit Program. The Request for Information ... explains that CBP intends to add biometrics to confirm ... States , in order to deter visa overstays, ... Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
(Date:6/15/2016)... , June 15, 2016 ... market report titled "Gesture Recognition Market by Application Market - Global ... 2016 - 2024". According to the report, the  global ... billion in 2015 and is estimated to grow ... 48.56 billion by 2024.  Increasing application ...
(Date:6/3/2016)... 3, 2016 Das ... Nepal hat ein 44 ... geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, ... Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte ... Januar teilgenommen, aber Decatur wurde als konformste ...
Breaking Biology News(10 mins):